MedTrace Logo

MRI and Biomarkers for Lung Nodules Detected During Lung Cancer Screening

NCT05699213 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 30

Last updated 2023-08-30

No results posted yet for this study

Summary

The primary objective of this pilot observational study is to evaluate the accrual and retention rate of a study population from a centralized lung cancer screening program to support MRI and blood-based biomarker research for lung cancer screening.

Conditions

Interventions

DIAGNOSTIC_TEST

Lung MRI

MRI of the lung

DIAGNOSTIC_TEST

Blood Draw

Blood Draw

Sponsors & Collaborators

  • Cedars-Sinai Medical Center

    lead OTHER

Principal Investigators

  • Sara Ghandehari, MD · Cedars-Sinai

Eligibility

Min Age
50 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-06-27
Primary Completion
2026-06-27
Completion
2026-08-27
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05699213 on ClinicalTrials.gov